References
- Bravo E.L., Tarazi R.C., Gifford R.W., Stewart B.H. “Circulating and Urinary Catecholamines in Pheochromocytoma,”. N. Eng. J. Med. 1979; 301: 682
- Chalfie M., Perlman R.L. “Studies of a Transplantable Rat Pheochromocytoma: Biochemical Characterization and Catecholamine Secretion,”. J. Pharmacol. Exp. Ther. 1976; 197: 615
- Colucci W.S., Gimbrone M.A., Alexander R.W. “Regulation of the Post-synaptic α-adrenergic receptor in Rat Mesenteric Artery: Effects of Chemical Sympathectomy and Epinephrine Treatment,”. Circ. Res. 1981; 48: 104
- Cooper B., Handin R.I., Young I.H., Alexander R.W. “Agonist Regulatoin of the Human Platelet Alpha-Adrenergic Receptor,”. Nature 1978; 274: 703
- Davies A.O., Lefkowitz R.J. “Regulation of Adrenergic Receptors,” in Receptor Regulation,”, R.J. Lefkowitz. Chapman and Hall. 1981
- Durrett L.R., Ziegler M.G. “A sensitive radioenzymatic assay for catechol drugs,”. J. Neurosci. Res. 1978; 5: 191
- El-Refai M.F., Blackmore P.F., Exton J.H. “Effects of Trypsin on Binding of [3H]Epinephrine and [3H]Dihydroergocryptine to Rat Liver Plama Membranes,”. J. Biol. Chem. 1979; 254: 4375
- Fraser J., Nadeau J., Robertson, Wood A.J.J. “Regulaton of Human Leukocyte Beta-Receptors by Endogenous Catecholamines: Relationship of Leukocyte Beta-Receptors to the Cardiac Sensitivity to Isoproterenol,”. J. Clin. Invest. 1981; 67: 1777
- Grant J.A., Scrutton M.C. “Interaction of Selective Alpha-adrenoceptor Agonists and Antagonists with Human and Rabbit Blood Platelets,”. Br. J. Pharmacol. 1980; 71: 121
- Greenacre J.K., Conolly M.E. “Desensitization of the α-Adrenoceptor of Lymphocytes from Normal Subjects and Patients with Phaeochromocytoma: Studies in vivo,”. Br. J. Clin. Pharmacol. 1973; 5: 191
- Hoffman B.B., DeLean A., Wood C.L., Schocken D.D., Lefkowitz R.J. “Alpha-adrenergic Receptor Subtypes: Quantitative Assessment by Ligand Binding,”. Life Sci. 1979; 24: 1739
- Hoffman B.B., Lefkowitz R.J. “[3H]WB4101: Caution about its Role as an Alpha-adrenergic Subtype-selective Radioligand,”. Biochem. Pharmacol. 1979; 29: 1537
- Hoffman B.B., Michel T., Mullikin-Kilpatrick D., Lefkowitz R.J., Tolbert M.E.M., Gilman H., Fain J.N. “Agonist versus Antagonist Binding to α-Adrenergic Receptors,”. Proc. Natl. Acad. Sci. USA 1980; 77: 4569
- Hsu C.Y., Knapp D.R., Halushka P.V. “The Effects of Al pha-adrenergic Agents on Human Platelet Aggregation,”. J. Pharmacol. Exp. Ther. 1979; 208: 366
- Insel P.A., Snavely M.D. “Catecholamines and the Kidney: Receptors and Renal Function,”. Annu. Rev. Physiol. 1981; 43: 625
- Jacobs K.H. “Synthetic Alpha-adrenergic Agonists are Potent Alpha-adrenergic Blockers in Human Platelets,”. Nature 1978; 274: 819
- Jarrett B., Louis W.J., Sommers R.J. “Characteristics of [3H]clonidine Binding to an α-Adrenoceptor in Membranes from Guinea Pig Kidney,”. Br. J. Pharmacol. 1979; 65: 663
- Kahn D.J., U'Prichard D.C. “Regulation of α2-Adrenergic Receptors in Neuroblastoma x Glioma Hybrid Cells,”. Soc. for Neurosci. 1981; 7: 429
- Karliner J.S., Motulsky H.J., Insel P.A. “Apparent Down-regulation of Human Platelet α2-Adrenergic Receptors is due to Retained Agonist,”. Mol. Pharmacol. 1982, in press
- Lynch C.J., Steer M.L. “Evidence for High and Low Affinity α2-Receptors: Comparison of [3H]norepinephrine and [3H]Phentolamine Binding to Human Platelet Membranes,”. J. Biol. Chem. 1981; 256: 3298
- McPherson G.A., Summers R.J. “[3H]Prazosin and [3H]Clonidine Binding to α-Adrenoceptors in Membranes Prepared from Regions of Rat Kidney,”. J. Pharm. Pharmacol. 1981; 33: 189
- Minneman K.P., Dibner M.D., Wolfe B.B., Molinoff P.B. “β1- and β2-Adrenergic Receptors in Rat Cerebral Cortex are Independently Regulated,”. Science 1979; 204: 866
- Motulsky H.J., Insel P.A. “Binding of Dihydroergocryptine to Al pha-adrenergic Receptors on Human Platelets: A Reassessment Using Selective Radioligands,”, (manuscript submitted)
- Motulsky H.J., Insel P.A. “Radioligand Binding to Adrenergic Receptors in Humans,”. Norepinephrine: Clinical Aspects, M. Ziegler, F. Lake. Williams and Williams, N. Y., (in press)
- Motulsky H.J., O'Connor D.T., Insel P.A. “Platelet Alpha2-adrenergic Receptor Number is Normal in Essential Hypertension and is Unaltered by Antihypertensive Therapy,”. Clin. Res. 1982, in press
- Motulsky H.J., Shattil S.J., Insel P.I. “Characterization of Alpha2-adrenergic Receptors on Human Platelets Using [3H]Yohimbine,”. Biochem. Biophys. Res. Commun. 1980; 74: 1562
- Moustafa E., Snavely M.D., Insel P.A. “Rat Renal Cortical β-Adrenergic Receptors are Primarily of the β1-Subtype,”. The Pharmacologist 1981; 23: 185
- Pettinger W., Sanchez A., Gandler T., Sanchez J., Saavedra J. “Dietary Sodium Regulates Abnormal Renal α-Adrenergic Receptors in the Dahl Hypertensive Rat,”. Clin. Res. 1981; 29: 276A
- Pettinger W., Sanchez A., Mulvihill-Wilson J., Saavedra J., Haywood J.R., Gandler T., Rodes T. “Renal and Platelet Alpha2-adrenergic Receptors in Hypertensive rats and Men,”. Hypertension 1981, in press
- Rouot B.R., Snyder S.H. “[3H]Para-amino-clonidine: A Novel Ligand which Binds with High Affinity to α-Adrenergic Receptors,”. Life Sci. 1979; 25: 769
- Shattil S.J., McDonough M., Turnbull J., Insel P.A. “Characterization of Al pha-adrenergic Receptors in Human platelets using [3H]Clonidine,”. Mol. Pharmacol. 1981; 19: 179
- Shenkman L., Saito M., Feih F., Goldstein M. “Reduced Number of Cardiac β-adrenergic Receptors in Rat Pheochromocytoma,”. Clin. Res. 1979; 27: 595A
- Snavely M.D., Insel P.A. “Characterization of Renal Cortical Beta-adrenergic Receptors,”. The Pharmacologist 1980; 22: 284
- Snavely M.D., Insel P.A. “Characterization of Al pha-adrenergic Receptor Subtypes in the Rat Renal Cortex: Differential Regulation of Alpha1- and Alpha2-adrenergic Receptors by Guanyl Nucleotides and Na+,”, (manuscript submitted)
- Snavely M.D., Insel P.A. “Binding of [3H]Prazosin and [3H]Yohimbine to α1 and α2-Adrenergic Receptors of Renal Cortical Membranes,”. Fed. Proc. 1981; 40: 1823
- Strittmatter W.S., Davis J.N., Lefkowitz R.J. “Al pha-adrenergic Receptors in Rat Parotid Cells: II. Desensitization of Receptor Binding Sites and Potassium Release,”. J. Biol. Chem. 1977; 252: 5478
- Su Y.-F., Harden T.K., Perkins J.P. “Catecholamine-specific Desensitization of Adenylate Cyclase,”. J. Biol. Chem. 1980; 255: 7410
- Summers R.J. “[3H]Clonidine Binding to α-adrenoceptors in Membranes Prepared from Regions of Guinea Pig Kidney: Alteration by Monovalent and Divalent Cations,”. Br. J. Pharmacol. 1980; 71: 57
- U'Prichard D.C., Snyder S.H. “Distinct α-Noradrenergic Receptors Differentiated by Binding and Physiological Relationships,”. Life Sci. 1979; 24: 79
- Warren S., Chute R.N. “Pheochromocytoma,”. Cancer 1972; 29: 327
- Warren S., Grozdev L., Gate O., Chute R.N. “Radiation-induced Adrenal Medullary Tumors in the Rat,”. Arch. Pathol. 1966; 82: 115
- Woodcock E.A., Funder J.W., Johnston C.I. “Decreased Cardiac β-adrenoceptors in Hypertensive Rats,”. Clin. Exp. Pharmacol. Physiol 1978; 5: 545
- Yamada S., Yamamura H.I., Roeske W.R. “Alterations in Central and Peripheral Adrenergic Receptors in Deoxycorticosterone/Salt Hypertensive Rats,”. Life Sci. 1980; 27: 2405
- Yu S.K., Latour J.G. “Potentiation by Alpha- and Inhibition by Beta-adrenergic Stimulations of Rat Platelet Aggregation. A Comparative Study with Human and Rat Platelets,”. Thrombos. Haemostas. 1977; 37: 413
- Zweifler A.J., Julius S. “Increased Platelet Catecholamine in Patients with Pheochromocytoma,”. Clin. Res. 1981; 29: 362A